药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzonatate
Guselkumab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Guselkumab.
Benzonatate
Sirukumab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Sirukumab.
Benzonatate
Brodalumab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Brodalumab.
Benzonatate
Peficitinib
The risk or severity of adverse effects can be increased when Sunitinib is combined with Peficitinib.
Benzonatate
Voclosporin
The risk or severity of adverse effects can be increased when Sunitinib is combined with Voclosporin.
Benzonatate
Pirarubicin
The risk or severity of adverse effects can be increased when Sunitinib is combined with Pirarubicin.
Benzonatate
Ravulizumab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Ravulizumab.
Benzonatate
Ixekizumab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Ixekizumab.
Benzonatate
Tepoxalin
The risk or severity of adverse effects can be increased when Sunitinib is combined with Tepoxalin.
Benzonatate
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Sunitinib is combined with Antilymphocyte immunoglobulin (horse).
Benzonatate
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Sunitinib is combined with Peginterferon beta-1a.
Benzonatate
Vilanterol
The risk or severity of adverse effects can be increased when Sunitinib is combined with Vilanterol.
Benzonatate
Dinutuximab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Dinutuximab.
Benzonatate
Blinatumomab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Blinatumomab.
Benzonatate
Vedolizumab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Vedolizumab.
Benzonatate
Obinutuzumab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Obinutuzumab.
Benzonatate
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Sunitinib is combined with Dimethyl fumarate.
Benzonatate
Carfilzomib
The risk or severity of adverse effects can be increased when Sunitinib is combined with Carfilzomib.
Benzonatate
Teriflunomide
The risk or severity of adverse effects can be increased when Sunitinib is combined with Teriflunomide.
Benzonatate
Belimumab
The risk or severity of adverse effects can be increased when Sunitinib is combined with Belimumab.